Clinical Trial Update: Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating intraperitoneal METR-NK cells as neoadjuvant therapy for advanced epithelial ovarian cancer is currently recruiting to assess safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• METR-NK cells

Snippet

Sponsor: Anhui Provincial Cancer Hospital | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: RECRUITING